Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Klf9em1/Cya
Common Name:
Klf9-KO
Product ID:
S-KO-02803
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Klf9-KO
Strain ID
KOCMP-16601-Klf9-B6J-VA
Gene Name
Klf9
Product ID
S-KO-02803
Gene Alias
2310051E17Rik; BTEB-1; Bteb1; Gm9971
Background
C57BL/6JCya
NCBI ID
16601
Modification
Conventional knockout
Chromosome
19
Phenotype
MGI:1333856
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Klf9em1/Cya mice (Catalog S-KO-02803) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000036884
NCBI RefSeq
NM_010638
Target Region
Exon 1
Size of Effective Region
~8.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Klf9, a Krüppel-like factor, is a transcription factor involved in multiple biological processes. It plays key roles in regulating mitochondrial homeostasis, energy metabolism, and cell differentiation. It is associated with pathways such as PPARγ/NRF2, Notch1-mediated signaling, and is crucial for maintaining cellular homeostasis in various cell types [1-10]. Genetic models, especially KO/CKO mouse models, have been instrumental in studying its functions.

Global and cardiac-specific Klf9-deficient mice showed hypertrophic cardiomyopathy, with Klf9 knockout leading to mitochondrial disarray, fragmentation, and impaired respiratory function in cardiomyocytes. It also inhibited mitophagy, accelerating heart failure upon angiotensin II treatment [1]. In diabetic cardiomyopathy, cardiac-specific overexpression of Klf9 deteriorated cardiac function, while silencing Klf9 ameliorated it, and Klf9 regulated PPARγ and NRF2 [2]. In hyperglycemia-aggravated bupivacaine neurotoxicity, Klf9 knockdown improved cell survival and mitochondrial function [3]. KLF9 deficiency protected the heart from inflammatory injury triggered by myocardial infarction by inhibiting NF-κB and MAPK signaling [4]. In dental stem cells, KLF9 promoted osteogenic differentiation by negatively regulating the Notch1-mediated signaling pathway [5]. In cardiomyocytes, Klf9 knockdown inhibited Dex-induced metabolic adaptations [6]. In COPD, inhibition of KLF9 alleviated airway inflammation [7]. In melanoma, Klf9-dependent ROS regulated tumor progression in a stage-specific manner [8]. Depletion of KLF9 compromised the osteogenic differentiation ability of mesenchymal stem cells [9]. KLF9 and KLF13 were important for oligodendrocyte differentiation and myelination [10].

In conclusion, Klf9 is essential for multiple biological functions including mitochondrial homeostasis, cell differentiation, and metabolic adaptations. The study of Klf9 using KO/CKO mouse models has provided insights into its role in diseases such as cardiomyopathy, diabetes-related heart diseases, neurotoxicity, myocardial infarction, and COPD, highlighting its potential as a therapeutic target.

References:

1. Zhang, Lei, Zhang, Menglin, Huang, Jinlong, Zhang, Jun, Chang, Yongsheng. 2024. Klf9 is essential for cardiac mitochondrial homeostasis. In Nature cardiovascular research, 3, 1318-1336. doi:10.1038/s44161-024-00561-6. https://pubmed.ncbi.nlm.nih.gov/39528719/

2. Li, Fangfang, Peng, Jingfeng, Feng, Hui, Qian, Wenhao, Zong, Jing. 2022. KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling. In Cells, 11, . doi:10.3390/cells11213393. https://pubmed.ncbi.nlm.nih.gov/36359788/

3. Li, Hui, Weng, Yaqian, Lai, Luying, Zhang, Yang, Li, Le. 2021. KLF9 regulates PRDX6 expression in hyperglycemia-aggravated bupivacaine neurotoxicity. In Molecular and cellular biochemistry, 476, 2125-2134. doi:10.1007/s11010-021-04059-8. https://pubmed.ncbi.nlm.nih.gov/33547545/

4. Chang, Zhihong, Li, Hongkun. . KLF9 deficiency protects the heart from inflammatory injury triggered by myocardial infarction. In The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 27, 177-185. doi:10.4196/kjpp.2023.27.2.177. https://pubmed.ncbi.nlm.nih.gov/36815257/

5. Zhao, Xinyuan, Mai, Zizhao, Lu, Ye, Cui, Li, Yu, Jinhua. . KLF9 Promotes Osteogenic Differentiation of Dental Stem Cells by Negatively Regulating Notch1 Mediated Signaling Pathway. In Frontiers in bioscience (Landmark edition), 28, 85. doi:10.31083/j.fbl2805085. https://pubmed.ncbi.nlm.nih.gov/37258472/

6. Thakkar, Chandni, Alikunju, Saleena, Niranjan, Nandita, Abdellatif, Maha, Sayed, Danish. 2023. Klf9 plays a critical role in GR -dependent metabolic adaptations in cardiomyocytes. In Cellular signalling, 111, 110886. doi:10.1016/j.cellsig.2023.110886. https://pubmed.ncbi.nlm.nih.gov/37690661/

7. Gu, Peijie, Wang, Zhen, Yu, Xin, Li, Yihang, Hu, Xiaodong. . Mechanism of KLF9 in airway inflammation in chronic obstructive pulmonary. In Immunity, inflammation and disease, 11, e1043. doi:10.1002/iid3.1043. https://pubmed.ncbi.nlm.nih.gov/37904708/

8. Bagati, Archis, Moparthy, Sudha, Fink, Emily E, Paragh, Gyorgy, Nikiforov, Mikhail A. 2019. KLF9-dependent ROS regulate melanoma progression in stage-specific manner. In Oncogene, 38, 3585-3597. doi:10.1038/s41388-019-0689-6. https://pubmed.ncbi.nlm.nih.gov/30664687/

9. Xiao, Xiaoxiao, Zhang, Ming, Qian, Yiwei, Wang, Xuepeng, Wu, Qiang. 2024. KLF9 regulates osteogenic differentiation of mesenchymal stem cells. In Journal of molecular histology, 55, 503-512. doi:10.1007/s10735-024-10204-6. https://pubmed.ncbi.nlm.nih.gov/38801643/

10. Bernhardt, Celine, Sock, Elisabeth, Fröb, Franziska, Nemer, Mona, Wegner, Michael. . KLF9 and KLF13 transcription factors boost myelin gene expression in oligodendrocytes as partners of SOX10 and MYRF. In Nucleic acids research, 50, 11509-11528. doi:10.1093/nar/gkac953. https://pubmed.ncbi.nlm.nih.gov/36318265/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest